Your browser doesn't support javascript.
loading
Epithelial ovarian cancer: An overview.
Desai, Arpita; Xu, Jingyao; Aysola, Kartik; Qin, Yunlong; Okoli, Chika; Hariprasad, Ravipati; Chinemerem, Ugorji; Gates, Candace; Reddy, Avinash; Danner, Omar; Franklin, Geary; Ngozi, Anachebe; Cantuaria, Guilherme; Singh, Karan; Grizzle, William; Landen, Charles; Partridge, Edward E; Rice, Valerie Montgomery; Reddy, E Shyam P; Rao, Veena N.
Affiliation
  • Desai A; Department of Internal Medicine, University of Buffalo, Erie County Medical Center, Buffalo, NY 14215, United States.
  • Xu J; Department of OB/GYN, Cancer Biology Program, Morehouse School of Medicine, Georgia Cancer Center for Excellence, Grady Health System, Atlanta, GA 30303, United States.
  • Aysola K; Department of OB/GYN, Cancer Biology Program, Morehouse School of Medicine, Georgia Cancer Center for Excellence, Grady Health System, Atlanta, GA 30303, United States.
  • Qin Y; Department of OB/GYN, Cancer Biology Program, Morehouse School of Medicine, Georgia Cancer Center for Excellence, Grady Health System, Atlanta, GA 30303, United States.
  • Okoli C; Department of OB/GYN, Cancer Biology Program, Morehouse School of Medicine, Georgia Cancer Center for Excellence, Grady Health System, Atlanta, GA 30303, United States.
  • Hariprasad R; Department of Internal Medicine, Morehouse School of Medicine, Grady Health System, Atlanta, GA 30303, United States.
  • Chinemerem U; Department of Internal Medicine, Morehouse School of Medicine, Grady Health System, Atlanta, GA 30303, United States.
  • Gates C; Department of OB/GYN, Cancer Biology Program, Morehouse School of Medicine, Georgia Cancer Center for Excellence, Grady Health System, Atlanta, GA 30303, United States.
  • Reddy A; Department of OB/GYN, Cancer Biology Program, Morehouse School of Medicine, Georgia Cancer Center for Excellence, Grady Health System, Atlanta, GA 30303, United States.
  • Danner O; Department of Surgery, Morehouse School of Medicine, Grady Health System, Atlanta, GA 30303, United States.
  • Franklin G; Department of OB/GYN, Cancer Biology Program, Morehouse School of Medicine, Georgia Cancer Center for Excellence, Grady Health System, Atlanta, GA 30303, United States.
  • Ngozi A; Department of OB/GYN, Cancer Biology Program, Morehouse School of Medicine, Georgia Cancer Center for Excellence, Grady Health System, Atlanta, GA 30303, United States.
  • Cantuaria G; NCI Cancer Program, Northside Hospital, Atlanta, GA 30342, United States.
  • Singh K; University of Alabama at Birmingham, Comprehensive Cancer Center, Birmingham AL 35294, United States.
  • Grizzle W; University of Alabama at Birmingham, Comprehensive Cancer Center, Birmingham AL 35294, United States.
  • Landen C; University of Alabama at Birmingham, Comprehensive Cancer Center, Birmingham AL 35294, United States.
  • Partridge EE; University of Alabama at Birmingham, Comprehensive Cancer Center, Birmingham AL 35294, United States.
  • Rice VM; Department of OB/GYN, Cancer Biology Program, Morehouse School of Medicine, Georgia Cancer Center for Excellence, Grady Health System, Atlanta, GA 30303, United States.
  • Reddy ES; Department of OB/GYN, Cancer Biology Program, Morehouse School of Medicine, Georgia Cancer Center for Excellence, Grady Health System, Atlanta, GA 30303, United States.
  • Rao VN; Department of OB/GYN, Cancer Biology Program, Morehouse School of Medicine, Georgia Cancer Center for Excellence, Grady Health System, Atlanta, GA 30303, United States.
World J Transl Med ; 3(1): 1-8, 2014 Apr 12.
Article in En | MEDLINE | ID: mdl-25525571
ABSTRACT
Ovarian cancer is the second most common gynecological cancer and the leading cause of death in the United States. In this article we review the diagnosis and current management of epithelial ovarian cancer which accounts for over 95 percent of the ovarian malignancies. We will present various theories about the potential origin of ovarian malignancies. We will discuss the genetic anomalies and syndromes that may cause ovarian cancers with emphasis on Breast cancer type 1/2 mutations. The pathology and pathogenesis of ovarian carcinoma will also be presented. Lastly, we provide a comprehensive overview of treatment strategies and staging of ovarian cancer, conclusions and future directions.
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: World J Transl Med Year: 2014 Document type: Article Affiliation country: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: World J Transl Med Year: 2014 Document type: Article Affiliation country: United States